Cargando…
Loss of MTSS1 results in increased metastatic potential in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) has a 5-year survival rate of 7%. This dismal prognosis is largely due to the inability to diagnose the disease before metastasis occurs. Tumor cell dissemination occurs early in PDAC. While it is known that inflammation facilitates this process, the underlyin...
Autores principales: | Zeleniak, Ann E, Huang, Wei, Brinkman, Mary K, Fishel, Melissa L, Hill, Reginald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369978/ https://www.ncbi.nlm.nih.gov/pubmed/28146435 http://dx.doi.org/10.18632/oncotarget.14869 |
Ejemplares similares
-
PTEN-Dependent Stabilization of MTSS1 Inhibits Metastatic Phenotype in Pancreatic Ductal Adenocarcinoma
por: Zeleniak, Ann E., et al.
Publicado: (2017) -
CANCER-ASSOCIATED FIBROBLAST EXOSOMES REGULATE SURVIVAL AND PROLIFERATION OF PANCREATIC CANCER CELLS
por: Richards, Katherine E., et al.
Publicado: (2016) -
A reciprocal feedback of Myc and lncRNA MTSS1-AS contributes to extracellular acidity-promoted metastasis of pancreatic cancer
por: Hu, Yuhang, et al.
Publicado: (2020) -
MTSS1 inhibits metastatic potential and induces G2/M phase cell cycle arrest in gastric cancer
por: Liu, Ke, et al.
Publicado: (2019) -
miRNA-182 regulated MTSS1 inhibits proliferation and invasion in Glioma Cells
por: Li, Zhexuan, et al.
Publicado: (2020)